240 related articles for article (PubMed ID: 17589895)
21. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery.
Wang Q; Tian X; Zhang C; Wang Q
Med Oncol; 2012 Dec; 29(4):2727-36. PubMed ID: 22101788
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
Deli G; Jin CH; Mu R; Yang S; Liang Y; Chen D; Makuuchi M
World J Gastroenterol; 2005 Feb; 11(7):960-3. PubMed ID: 15742396
[TBL] [Abstract][Full Text] [Related]
25. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α and HIF-2α: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation.
Wu L; Fu Z; Zhou S; Gong J; Liu CA; Qiao Z; Li S
PLoS One; 2014; 9(2):e88913. PubMed ID: 24551189
[TBL] [Abstract][Full Text] [Related]
27. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and prognostic significance of HIF-1α and HIF-2α expression in small cell lung cancer.
Luan Y; Gao C; Miao Y; Li Y; Wang Z; Qiu X
Pathol Res Pract; 2013 Mar; 209(3):184-9. PubMed ID: 23375698
[TBL] [Abstract][Full Text] [Related]
29. Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma.
Sakaguchi T; Suzuki S; Higashi H; Inaba K; Nakamura S; Baba S; Kato T; Konno H
J Surg Res; 2008 Jun; 147(1):123-31. PubMed ID: 17981296
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
31. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.
Geis T; Döring C; Popp R; Grossmann N; Fleming I; Hansmann ML; Dehne N; Brüne B
Exp Cell Res; 2015 Feb; 331(1):46-57. PubMed ID: 25489981
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
33. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
34. [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].
Cao MQ; Gao JR; Huang JF; You AB; Guo ZG; Zhou HY; Fang F; Zhang W; Zhu XL; Zhang T
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):18-23. PubMed ID: 28104028
[No Abstract] [Full Text] [Related]
35. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
36. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
[TBL] [Abstract][Full Text] [Related]
37. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]